CanSino Biologics Inc

Common Name
CanSino Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,105
Ticker
688185
Exchange
SHANGHAI STOCK EXCHANGE
Description
CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for...

CanSino Biologics's Climate Target Data Preview

As of 2023, CanSino Biologics has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 intensity-based targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into CanSino Biologics ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Square Meter (m2)
Copy restricted. Please purchase to unlock this data.
2025
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Square Meter (m2)
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into CanSino Biologics's Greenhouse Gas Emissions Pathways

As of 2023, CanSino Biologics has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does CanSino Biologics have a target to reduce the emissions from its operations?

As of 2023, CanSino Biologics has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

CanSino Biologics's most ambitious operational target is to reduce these emissions by 50% by 2030, compared to a baseline of 0.54 Metric Tonnes of CO2 equivalent (mtCO2e) per Square Meter (m2) in 2021.

As of 2023, CanSino Biologics is ahead of schedule on its operational emissions reduction target, having achieved 44.44% of the planned reduction.

CanSino Biologics's Operational (Scope 1+2) Emissions Pathway

202120232025203000.150.30.450.6BaselineCurrent (-22%)Target 2030 (-50%)
Want Full Access to CanSino Biologics's Climate Targets Dataset?
Sign Up